A previous study indicated that ATR contributes to the chemotherapeutic resistance of GBM and malignant melanoma.36 Whether NUSAP1 is involved in the chemotherapeutic resistance of GBM remains unclear. This evidence concerns the gene ATR and glioblastoma.